RayzeBio, Inc. (RYZB) Misses Q3 EPS by 57c

RayzeBio, Inc. (NASDAQ: RYZB) reported Q3 EPS of ($1.26), $0.57 worse than the analyst estimate of ($0.69).

For earnings history and earnings-related data on RayzeBio, Inc. (RYZB) click here.

You May Also Be Interested In

• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• Dollar Tree (DLTR) Tops Q2 EPS by $1.59, Beats on Revenue; Offers FY Guidance
• Northland lifts Semtech rating, sees connectivity as the AI bottleneck